November 24, 2025Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP Biodexa ...
The B-FREE Chronic Babesiosis Study ( NCT06656351) is a Phase 2 open-label study that will evaluate the efficacy (and safety) of the ARAKODA ® regimen of tafenoquine over 90 days for resolution of ...
Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol 22-May-2024 / 17:40 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is ...
Wells Fargo lowered the firm’s price target on Site Centers (SITC) to $14.50 from $17 and keeps an Equal Weight rating on the shares. The firm believes leasing demand remains strong. However, Wells ...
Compass Point analyst Floris van Dijkum maintained a Hold rating on SITE Centers (SITC – Research Report) today and set a price target of $17.00. The company’s shares closed yesterday at $17.09.
07.11.2023 / 07:00 CET/CEST PRESS RELEASE Zug, 7. November 2023 Detlef Trefzger nominated for election to the Board of Directors Christopher Chambers will not stand for re-election in March 2024 ...
TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in ...
VANCOUVER, British Columbia, Jan. 03, 2020 (GLOBE NEWSWIRE) -- Doteasy, a leading Canadian web hosting company, announced their partnership with Website.com, adding the easy drag + drop site builder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback